FDA+ roundup: Marks on Woodcock's tenure as acting commissioner; FDA leaders offer perspective on barriers to diversity in research
CBER director Peter Marks praised Janet Woodcock’s work as acting FDA commissioner, and while noting that Biden needs to nominate someone to fill the role …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
